Tonix Pharmaceuticals Provides Update On Development of Its Single Dose Live Attenuated Virus Vaccine Candidate For Mpox: Company Says TNX-801 Will Provide Long-term Protection From Mpox & Smallpox With One Dose
Author: Benzinga Newsdesk | August 16, 2024 07:12am